Han Ro

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

IL-2/Anti-IL-2 Complex Attenuates Renal Ischemia-Reperfusion Injury through Expansion of Regulatory T Cells

Myung-Gyu Kim, Tai Yeon Koo, Ji-Jing Yan et al. · Journal of the American Society of Nephrology · 2013 · 97 citations · Full text

T-regulatory Cell, Immunology, Renal Inflammation +20

The clinical significances of simple renal cyst: Is it related to hypertension or renal dysfunction?

Ho Jun Chin, Han Ro, Hyukjun Lee et al. · Kidney International · 2006 · 94 citations · Full text

Glomerulonephritis, Urology, Renal Function +9

Impact of Tacrolimus Intraindividual Variability and CYP3A5 Genetic Polymorphism on Acute Rejection in Kidney Transplantation

Han Ro, Sangil Min, Jaeseok Yang et al. · Therapeutic Drug Monitoring · 2012 · 80 citations